HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Defective signaling through plexin-A1 compromises the development of the peripheral olfactory system and neuroendocrine reproductive axis in mice.

Abstract
The olfacto-genital syndrome (Kallmann syndrome) associates congenital hypogonadism due to gonadotropin-releasing hormone (GnRH) deficiency and anosmia. This is a genetically heterogeneous developmental disease with various modes of transmission, including oligogenic inheritance. Previous reports have involved defective cell signaling by semaphorin-3A in the disease pathogenesis. Here, we report that the embryonic phenotype of Plxna1-/- mutant mice lacking plexin-A1 (a major receptor of class 3 semaphorins), though not fully penetrant, resembles that of Kallmann syndrome fetuses. Pathohistological analysis indeed showed a strongly abnormal development of the peripheral olfactory system and defective embryonic migration of the neuroendocrine GnRH cells to the hypothalamic brain region in some of the mutant mice, which resulted in reduced fertility in adult males. We thus screened 250 patients for the presence of mutations in PLXNA1, and identified different nonsynonymous mutations (p.V349L, p.V437L, p.R528W, p.H684Y, p.G720E, p.R740H, p.R813H, p.R840Q, p.A854T, p.R897H, p.L1464V, p.K1618T, p.C1744F), all at heterozygous state, in 15 patients. Most of these mutations are predicted to affect plexin-A1 stability or signaling activity based on predictive algorithms and a structural model of the protein. Moreover, in vitro experiments allowed us to show the existence of deleterious effects of eight mutations (including a transcript splicing defect), none of which are expected to result in a complete loss of protein synthesis, targeting, or signaling activity, though. Our findings indicate that signaling insufficiency through plexin-A1 can contribute to the pathogenesis of Kallmann syndrome, and further substantiate the oligogenic pattern of inheritance in this developmental disorder.
AuthorsSéverine Marcos, Carine Monnier, Xavier Rovira, Corinne Fouveaut, Nelly Pitteloud, Fabrice Ango, Catherine Dodé, Jean-Pierre Hardelin
JournalHuman molecular genetics (Hum Mol Genet) Vol. 26 Issue 11 Pg. 2006-2017 (06 01 2017) ISSN: 1460-2083 [Electronic] England
PMID28334861 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Nerve Tissue Proteins
  • PLXNA1 protein, human
  • Plxna1 protein, mouse
  • Receptors, Cell Surface
  • Semaphorin-3A
  • Semaphorins
  • Gonadotropin-Releasing Hormone
Topics
  • Adult
  • Animals
  • Cell Movement
  • Female
  • Gonadotropin-Releasing Hormone (deficiency)
  • Heterozygote
  • Humans
  • Hypogonadism (genetics)
  • Hypothalamus (metabolism)
  • Kallmann Syndrome (metabolism)
  • Male
  • Mice
  • Mutation
  • Nerve Tissue Proteins (genetics, metabolism, physiology)
  • Neuroendocrine Cells (metabolism)
  • Neurons (metabolism)
  • Olfactory Bulb (physiology)
  • Receptors, Cell Surface (genetics, metabolism, physiology)
  • Reproduction
  • Semaphorin-3A (genetics, metabolism)
  • Semaphorins (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: